Approval · Notice of Compliance 16002 · 2014
REACTINE FAST MELT JUNIOR: Notice of Compliance 16002
Issued June 18, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16002
- Date
- June 18, 2014
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change to the product name from reactine fast melts to reactine fast melt junior and changes to the labelling documents
- Therapeutic class
- Antihistamine
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE FAST MELT JUNIOR | 02358352 | Marketed |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 10 MG per TAB